91 related articles for article (PubMed ID: 1813057)
1. The therapeutic and biological effects of total lymph node irradiation and autologous bone marrow infusion on malignant lymphoma patients.
Yu S; Chen Z; Chen Y; Jiang C; Guo T; Jiang B; Gao P; Kong X
Chin Med Sci J; 1991 Dec; 6(4):197-202. PubMed ID: 1813057
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.
Abrams RA; Liu PJ; Ambinder RF; Haulk TL; Korman LT; Herman MG; Jones RJ
Radiology; 1997 Jun; 203(3):865-70. PubMed ID: 9169718
[TBL] [Abstract][Full Text] [Related]
3. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Da WM; Zhong JT; Liu Y; Huang YS; Bai H; Wu XX; Ou YX; Wang CB; Xu SF
Chin Med J (Engl); 1993 Apr; 106(4):277-81. PubMed ID: 8325155
[TBL] [Abstract][Full Text] [Related]
4. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.
Ghalie R; Richman CM; Adler SS; Korenblit AD; Kramer TS; Manson S; Dolce A; Kaizer H
Bone Marrow Transplant; 1991 Jul; 8(1):41-5. PubMed ID: 1912954
[TBL] [Abstract][Full Text] [Related]
5. [High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience].
Stahel RA; Jost LM; Burger J; Honegger HP; Brun del Re GP; Gmür J
Schweiz Med Wochenschr; 1989 Jun; 119(25):911-7. PubMed ID: 2667131
[TBL] [Abstract][Full Text] [Related]
6. [Total body irradiation and bone marrow transplant].
Martinenghi C; Villa E; Fossati V; Beatrice S
Radiol Med; 1986 Oct; 72(10):705-14. PubMed ID: 3534969
[TBL] [Abstract][Full Text] [Related]
7. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Petersen FB; Appelbaum FR; Bigelow CL; Buckner CD; Clift RA; Sanders JE; Storb R; Sullivan KM; Weiden PL; Fefer A
Bone Marrow Transplant; 1989 Sep; 4(5):483-8. PubMed ID: 2676043
[TBL] [Abstract][Full Text] [Related]
8. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
[TBL] [Abstract][Full Text] [Related]
9. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
[TBL] [Abstract][Full Text] [Related]
10. [Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].
Da WM; Zhong JT; Huang YS
Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):640-2, 660. PubMed ID: 1582346
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
12. Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation.
Sullivan KM; Appelbaum FR; Horning SJ; Rosenberg SA; Thomas ED
Int J Cell Cloning; 1986; 4 Suppl 1():94-106. PubMed ID: 3528333
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
14. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.
Brice P; Marolleau JP; Dombret H; Lepage E; Baruchel A; Adam M; Miclea JM; Sitthy X; Gisselbrecht C
Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
Philip T; Armitage JO; Spitzer G; Chauvin F; Jagannath S; Cahn JY; Colombat P; Goldstone AH; Gorin NC; Flesh M
N Engl J Med; 1987 Jun; 316(24):1493-8. PubMed ID: 3295541
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.
Kvalheim G; Jakobsen E; Holte H; Beiske K; Langholm R; Høiby A; Wang MY; Funderund S; Fodstad O; Smeland E
Prog Clin Biol Res; 1994; 389():133-8. PubMed ID: 7700895
[No Abstract] [Full Text] [Related]
17. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation.
Jules-Elysee K; Stover DE; Yahalom J; White DA; Gulati SC
Am Rev Respir Dis; 1992 Aug; 146(2):485-91. PubMed ID: 1489145
[TBL] [Abstract][Full Text] [Related]
18. Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.
Braine HG; Santos GW; Kaizer H; Yeager AM; Mann RB; Burns WH; Civin CI; Fuller DJ; Rowley SD; Saral R
Bone Marrow Transplant; 1987 Jun; 2(1):7-14. PubMed ID: 3332159
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
[TBL] [Abstract][Full Text] [Related]
20. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
